The ongoing prospective study (ChiCTR20000301150) evaluating both serum cortisol and ACTH levels in COVID-19 patients is expected to give a better insight into the prevalence and etiology of COVID-19-associated AI (59). This evidence concerns the gene POMC and COVID-19.